Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $64.92. The company's market cap stands at 137.61B, with a P/E ratio of 17.71 and a dividend yield of 4.62%.
On 2026-07-30, Bristol-Myers Squibb(BMY) stock traded between a low of $62.23 and a high of $65.56. Shares are currently priced at $64.92, which is +4.3% above the low and -1.0% below the high.
Bristol-Myers Squibb(BMY) shares are trading with a volume of 18.03M, against a daily average of 10.29M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $65.56 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $65.56 and a 52-week low of $42.52.
BMY News
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Not for the first time this year, Bristol Myers Squibb (BMY +2.79%) posted an impressive quarterly earnings report Thursday morning. Investors clearly found muc...
Looking at the universe of stocks we cover at Dividend Channel , in trading on Tuesday, shares of Bristol Myers Squibb Co. (Symbol: BMY) were yielding above the...
Analyst ratings
61%
of 31 ratingsMore BMY News
• Bristol-Myers Squibb stock is showing upward movement. Why are BMY shares climbing? The U.S. large pharma company reported adjusted earnings of $2.04, beatin...
William Blair analyst Matt Phipps has maintained their neutral stance on BMY stock, giving a Hold rating on July 27. Unlock powerful investing tools with TipRa...
In recent days, Bristol-Myers Squibb has drawn attention as analysts revised earnings expectations, a partner sought approval for an Opdivo combination therapy,...
Bristol-Myers Squibb (BMY) is projected to report a nearly 10% jump in its Q2 earnings when it reports its results on July 29, after the closing bell. Wall Str...
Analysts expect the company to report quarterly earnings of $1.60 per share, up from $1.46 per share in the year-ago period. The consensus estimate for Bristol-...
Bristol-Myers Squibb stock has delivered a strong 42.2% return over the past year, while the current valuation checks show a mixed picture and the Discounted Ca...
Artificial intelligence (AI) is changing every industry, and even companies outside the technology sector are partnering with Nvidia (NVDA +0.28%), one of the l...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.